To investigate the relationship between the expression of PD-L1, PD-1, TS and the clinicopathologic features of patients with advanced lung adenocarcinoma, who received pemetrexed-based treatment, the χ2 test was performed. The gene discussed is TYMS; the disease is lung adenocarcinoma.